Freeze and fight: new combo therapy aims to save bladders in High-Risk cancer
NCT ID NCT07204132
Summary
This study tests a new approach to treat high-risk bladder cancer without removing the bladder. It combines freezing the tumor during surgery with immunotherapy and low-dose chemotherapy. The goal is to control the cancer while preserving the bladder and quality of life. The study will enroll 180 adults with high-risk non-muscle-invasive bladder cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ChangHai Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.